US FDA targets “lawful pathways” for CBD marketing, warns about “unfounded” health claims

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

25 Jan 2021 --- Amyris is acquiring Terasana – a natural skincare brand – to launch a branded clean beauty product focused on sustainably sourced... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Jan 2021 --- Neuropathix (formerly known as Kannalife) has landed a patent for its hops-inspired synthesized neuroprotectant, NPTX-204. The pharmaceutical ingredient is based on... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

04 Jan 2021 --- Following the end of a busy year in nutrition news, NutritionInsight provides an overview of the various business developments over the holiday period to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

23 Dec 2020 --- The year saw COVID-19 tint every facet of nutrition, as the pandemic’s march caused industry disruptions and heightened interest in immunity. From... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Dec 2020 --- The US Federal Trade Commission (FTC) issued its first legal enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products in the... Read More

trans